Results 161 to 170 of about 56,186 (320)

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Neuromodulatory subcortical systems (NSSs) are uniquely susceptible to dementia‐related pathology, leading to frequent molecular and behavioral impairments associated with altered function of these nuclei. Some of these systems display clear sex‐specific cytoarchitecture and signaling leading to distinct physiology and behavioral outputs in ...
Rosaria J. Rae, Jessica Marie Hunter Alberhasky, Marion Baillet, Debra A. Bangasser, Michael E. Belloy, Anne S. Berry, Chiara Berteotti, Hannah Bow, Rachel Buckley, Jessica Z. K. Caldwell, Matteo Carpi, Benjamin J. Clark, Claire J. Ciampa, Alexander C. Conley, Martin J. Dahl, Zoe R. Donaldson, Alexander J. Ehrenberg, Gillian Einstein, Neus Falgàs, Haley A. Fenlon, Megan C. Fitzhugh, Robert C. Froemke, Clara Gallay, Lea Tenenholz Grinberg, Derek A. Hamilton, Zia Hasan, Oihane Uriarte Huarte, Shaista Jabeen, Heidi I. L. Jacobs, Louis John Kolling, Elouise A. Koops, Sabrina Lenzoni, Claudio Liguori, Riccardo Manca, Catherine A. Marcinkiewcz, Tamunotonye Omoluabi, Rademene Oria, Caitlin A. Orsini, Nancy Elizabeth Ortega, Judy Pa, Nathan S. Pentkowski, Joana B. Pereira, Rhudovic Ramos, Derya Sargin, Abhijit Satpati, Maria Clara Selles, Mabel Seto, Shabana M. Shaik, Shireen Sindi, Gowoon Son, Valentine Ucheagwu, Maxime Van Egroo, Qi Yuan, Michael A. Kelberman   +53 more
wiley   +1 more source

Clinical utilities of aromatase inhibitors in breast cancer

International Journal of Women's Health, 2015
Saranya Chumsri Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA Abstract: Aromatase is an enzyme that converts testosterones to estrogens.
Chumsri S
doaj  

Symptom Clusters and Symptom Burden in Cancer Survivors

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Context Limited information is available on the symptom burden and symptom clusters in cancer survivors. Objectives Describe the occurrence, severity, and distress of 44 symptoms; determine risk factors associated with a higher symptom burden; and evaluate for symptom clusters using symptom occurrence rates.
Marilyn J. Hammer, Carolyn Harris, Rachel Pozzar, Karin Snowberg, Steven M. Paul, Bruce A. Cooper, Maura E. Abbott, Susan Chang, Stacey Kenfield, Erin Van Blarigan, Katherine Van Loon, Jon D. Levine, Christine Miaskowski   +12 more
wiley   +1 more source

Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis [PDF]

, 2017
Hadar Goldvaser, T. Barnes, Boštjan Šeruga, David W. Cescon, Alberto Ocaña, Domen Ribnikar, Eitan Amir   +6 more
openalex   +1 more source

Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer

, 2022
Jessica A. Martinez, Betsy C. Wertheim, Denise J. Roe, Pavani Chalasani, Jules Cohen, Lea Baer, H.‐H. Sherry Chow, Alison Stopeck, Patricia A. Thompson   +8 more
openalex   +2 more sources

Male Breast Cancer: Growing Insights and Continuing Challenges

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Breast cancer (BC) in men accounts for less than 1% of all BC diagnoses worldwide. Despite its low incidence, the number of men being diagnosed is increasing. Historically perceived as a predominantly female disease, BC in men has received comparatively limited attention.
Sahar Iftikhar, Elissa Burr, Amal Freigoun, Theo Nearney, Christelle Q. Kanda, Hazel Robinson, Caroline Vermeren, Udana Wickramaratne, Matthew Everest, Luca Foley, Valerie Speirs   +10 more
wiley   +1 more source

Aromatase Inhibitor [PDF]

, 2020
openaire   +1 more source

Comparison of docking procedures and its efficiency for Betasecretase, Aromatase and Pyruvate dehydrogenase kinase inhibitors

, 2017
Zahra Rezaei, Masood Fereidoonnezhad, Zeinab Faghih, Hossein Sadeghpur, Ayyub Mojaddami, Amirhossein Sakhteman   +5 more
openalex   +2 more sources

Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter? [PDF]

, 2008
William R. Miller, John M.S. Bartlett, Angela Brodie, Robert W. Brueggemeier, E. Di Salle, Per Eystein Lønning, Antonio Llombart‐Cussac, Nicolaì Maass, Thierry Maudelondé, Hironobu Sasano, Paul E. Goss   +10 more
openalex   +1 more source

Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer – A Review [PDF]

, 2021
Dragoş Şerban, Daniel Ovidiu Costea, Anca Zgură, M Tudosie, Ana Maria Dascălu, Gabriel Andrei Gangura, Catalin Gabriel Smarandache, Alexandru Dan Sabău, Corneliu Tudor, Mihai Faur, Andreea Costea, Daniela Stana, Simona Balasescu, Laura Tribus, Ciprian Tănăsescu   +14 more
openalex   +1 more source